AirSculpt Technologies, Inc. (AIRS)
USD 5.85
(-7.0%)
USD 5.85
(-7.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 118.32 Million USD | -14.51% |
| 2022 | 109.47 Million USD | 51.36% |
| 2021 | 72.32 Million USD | 147.18% |
| 2020 | 29.26 Million USD | 16.65% |
| 2019 | 25.08 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 30.08 Million USD | 90.92% |
| 2024 Q1 | 15.75 Million USD | -35.13% |
| 2023 Q2 | 30.4 Million USD | 15.98% |
| 2023 Q1 | 26.21 Million USD | -12.79% |
| 2023 FY | 93.59 Million USD | -14.51% |
| 2023 Q4 | 24.28 Million USD | -12.19% |
| 2023 Q3 | 27.65 Million USD | -9.04% |
| 2022 Q1 | 26.05 Million USD | -29.09% |
| 2022 Q3 | 25.39 Million USD | -9.23% |
| 2022 Q2 | 27.97 Million USD | 7.37% |
| 2022 FY | 109.47 Million USD | 51.36% |
| 2022 Q4 | 30.06 Million USD | 18.4% |
| 2021 Q2 | 11.86 Million USD | 16.9% |
| 2021 FY | 72.32 Million USD | 147.18% |
| 2021 Q4 | 36.73 Million USD | 169.72% |
| 2021 Q3 | 13.62 Million USD | 14.81% |
| 2021 Q1 | 10.14 Million USD | 13.03% |
| 2020 Q4 | 8.97 Million USD | 17.66% |
| 2020 Q3 | 7.63 Million USD | 9.3% |
| 2020 Q2 | 6.98 Million USD | 0.0% |
| 2020 Q1 | 6.98 Million USD | 0.0% |
| 2020 FY | 29.26 Million USD | 16.65% |
| 2019 FY | 25.08 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 32.777% |
| Addus HomeCare Corporation | 248.92 Million USD | 52.466% |
| Amedisys, Inc. | 834.47 Million USD | 85.821% |
| American Oncology Network, Inc. | 83.97 Million USD | -40.901% |
| Astrana Health, Inc. | 112.59 Million USD | -5.085% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 79.855% |
| IMAC Holdings, Inc. | 5.02 Million USD | -2253.671% |
| biote Corp. | 98.82 Million USD | -19.728% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -236.09% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 64.962% |
| COMPASS Pathways plc | 136.91 Million USD | 13.582% |
| DocGo Inc. | 180.32 Million USD | 34.385% |
| The Ensign Group, Inc. | 335.39 Million USD | 64.721% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 37.426% |
| InnovAge Holding Corp. | 558.25 Million USD | 78.805% |
| Assure Holdings Corp. | 15.43 Million USD | -666.384% |
| The Joint Corp. | 109.22 Million USD | -8.331% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 75.913% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -548.62% |
| ModivCare Inc. | 586.89 Million USD | 79.839% |
| NewGenIvf Group Limited | 1.63 Million USD | -7116.767% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -776.078% |
| Option Care Health, Inc. | 666.62 Million USD | 82.251% |
| P3 Health Partners Inc. | 199.56 Million USD | 40.71% |
| P3 Health Partners Inc. | 199.56 Million USD | 40.71% |
| The Pennant Group, Inc. | 88.99 Million USD | -32.954% |
| Surgery Partners, Inc. | 319.5 Million USD | 62.967% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -2651.995% |
| Talkspace, Inc. | 97.58 Million USD | -21.245% |
| Talkspace, Inc. | 97.58 Million USD | -21.245% |
| The Oncology Institute, Inc. | 136.59 Million USD | 13.375% |
| The Oncology Institute, Inc. | 136.59 Million USD | 13.375% |